関連する実験動画

Updated: Sep 9, 2025

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Humanized NOD/SCID/IL2rγ^null (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

症例報告:シムノトレルビル/リトナビルは,毛細血管リンパ腫患者の抗CD20維持療法中の長期間続くSARS-CoV-2感染の経過を短縮するのに有効です

Jing Yang¹, Shengke Tu¹, Hui Peng¹

¹Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou, Hunan, China.

Frontiers in oncology

|August 29, 2025

まとめ

血液学的悪性腫瘍を有する患者は,特に抗CD20療法を受けている患者は,持続的なCOVID-19を発症することがあります. これは,免疫力が低下した個体における長期間続くSARS-CoV-2感染の診断と治療における課題を強調しています.

科学分野:

血液学
感染症
腫瘍学

背景:

血液学的悪性腫瘍,特にリンパ腫の患者は,長時間または再発的なCOVID-19感染に脆弱である.
抗CD20モノクローナル抗体療法 (例:リトゥキシマブ,オビヌツズマブ) は免疫反応を低下させ,感受性を高める可能性があります.
ワクチン接種状態は,この集団における持続的なSARS-CoV-2のリスクを完全に軽減しません.

研究の目的:

血液学的悪性腫瘍患者のSARS-CoV-2 (COVID-19) 感染症の複雑さを強調する.
この脆弱な集団でCOVID-19が長引く理由について議論します.
抗CD20治療中に原因不明の呼吸器症状の管理戦略を探る.

主な方法:

2人の卵泡リンパ腫患者の症例報告オミクロン変異の感染が持続した.
抗CD20薬 (オビヌツズマブ,リトキシマブ),免疫調節薬,シムノトレルビル/ リトナビルを含む治療の分析
診断の課題と臨床の経過について

主要な成果:

2人の卵泡性リンパ腫患者で,常時的なSARS-CoV-2検査で検出されなかった,持続的なオミクロン感染症を経験した.
症状の緩和は,他の治療に加え,シムノトレルビル/ リトナビールを投与することで達成された.
抗CD20剤を服用している血液性悪性腫瘍の患者は,長期間続くCOVID-19のリスクが高い.

結論:

血液学的悪性腫瘍患者の抗CD20治療は,長続きし再発するCOVID-19の重大なリスクを伴います.
これらの患者の原因不明の呼吸器症状は慎重に評価する必要があります.
専門的な予防,診断,治療戦略の開発は,この患者グループにとって極めて重要です.

キーワード:

コロナウイルス SARS-CoV-2についてシムノトレルビール/ リトナビールアンチCD20 卵泡リンパ腫感染症

さらに関連する動画

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

関連する概念動画

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Myocarditis IV: Nursing Management

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...